<DOC>
	<DOCNO>NCT02241525</DOCNO>
	<brief_summary>Examine feasibility efficacy individually optimize uniform contrast enhancement CT pulmonary angiography ( CTPA ) diagnosis pulmonary thromboembolic disease .</brief_summary>
	<brief_title>CT Pulmonary Thromboembolic Disease</brief_title>
	<detailed_description>Patient characteristic , qualitative image quality score , quantitative contrast enhancement CNR describe use mean value standard deviation continuous variable , frequency percent categorical variable . Difference two patient group compare use Wilcoxon sign rank test chi-square statistic continuous categorical variable , respectively . All statistical test perform significance level 0.05 .</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>Patients 18 year old old Patients recommend CTPA scan diagnosis pulmonary ; thromboembolic disease ( PE ) Department Diagnostic Radiology Nuclear Medicine University MarylandPatients whose body mass index ( BMI ) great 30 kg/m2 . Patients whose body mass index ( BMI ) great 30 kg/m2 Patients sign University Maryland Medical Center Consent Intravenous Contrast Administration Pregnant breastfeed woman ; Female participant childbearing age ( 10 60 year ) screen pregnancy status prior study registration , follow Department Diagnostic Radiology Nuclear Medicine CLINICAL STANDARD Procedure DIAOP003 `` Pregnancy Screening Documentation '' ; Patients decrease renal function3436 . This evaluate blood work check within 30 day prior CTPA scan contrast . Patients receive contrast BUN index within [ 720 ] creatinine within [ 0.5 1.4 ] mg/dL Patients decrease renal function3436 . This evaluate blood work check within current admission inpatient within 30 day outpatient prior CTPA scan contrast . Patients receive contrast serum creatinine level exceeds 2.0 mg/dL Patients know moderate severe allergic reaction contrast , include limited : shortness breath , change baseline vital sign , change blood pressure , tachycardia , increase respiration progress major respiratory distress , laryngeal edema , bronchospasm , arrhythmia , convulsion , cardiopulmonary arrest .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Pulmonary</keyword>
	<keyword>Thromboembolic</keyword>
	<keyword>Lung</keyword>
</DOC>